Patients in GP surgeries in Bristol are being invited to take part in a large trial of low-dose amitriptyline for irritable bowel syndrome (IBS) led by researchers from the universities of Bristol, Leeds and Southampton.
Stunning art that captures the experience of studying first year medicine during a pandemic features in a moving online exhibition.
Dr Richard Bolster, Lecturer in French (then Senior Research Fellow) at Bristol from 1965 to 2005, died late in 2015.
Targeted testing of individuals with a range of signs and symptoms could improve diagnosis of coeliac disease, a new National Institute for Health Research (NIHR) funded study led by the University of Bristol and published in PLOS ONE has found. Signs and symptoms include family history of coeliac disease, dermatitis herpetiformis, anaemia, type 1 diabetes, osteoporosis and chronic liver disease.
Researchers have discovered that intelligent birds have unique welfare needs in captivity.
A new simple blood test for brain tumours that could be used by GPs in primary care will be developed thanks to funding of nearly £500,000 by Cancer Research UK. Around 60,000 patients in the UK are living with a brain tumour but only 20 per cent of patients are still alive five years after diagnosis, partly because they present late with large inoperable tumours.
The University of Bristol’s South West Nuclear Hub has entered into a strategic relationship with the National Nuclear Laboratory (NNL), who undertake applied nuclear research and development with a key role in supporting government and industry in strategic nuclear programmes.
UK and China embark on ambitious research to simultaneously prevent obesity and under-nutrition.
One in five young people have fatty liver disease (steatosis), with one in 40 having already developed liver scarring (fibrosis), research published today [15 January] has found. The study, published in The Lancet Gastroenterology & Hepatology, is the first to attempt to determine the prevalence of fatty liver disease and fibrosis in young healthy adults in the UK.
The University of Bristol’s Advanced Composites Centre for Innovation and Science (ACCIS) has announced an innovative new EPSRC-funded collaboration with the University of Nottingham.
